News - Immunologicals


Current filters:


Popular Filters

40 to 64 of 129 results

Stallergenes report growth in third quarter results


French allergy specialists Stallergenes has released its third quarter results showing revenue growth…


Stallergenes and DBV Technologies collaborate in birch pollen allergy research


French allergy specialists Stallergenes and DBV Technologies, creator of Viaskin for the treatment of…

DBV TechnologiesImmunologicalsPharmaceuticalResearchRespiratory and PulmonaryStallergenes

ALK’s allergy tablet falls victim to US government shutdown

ALK’s allergy tablet falls victim to US government shutdown


ALK Abello is the first pharma casualty of the US government shutdown.

ALK AbelloImmunologicalsMerk & CoNorth AmericaPharmaceuticalRegulation

Gliknik enters licensing agreement with Pfizer


Gliknik has entered into an exclusive worldwide licensing agreement with Pfizer for GL-2045, which is…

BiotechnologyGliknikImmunologicalsLicensingNorth AmericaOncologyPfizer

CSL Behring’s Hizentra approved in Japan for PID and SID

CSL Behring’s Hizentra approved in Japan for PID and SID


The Japanese Ministry of Health, Labor and Welfare has approved Hizentra for the treatment of primary…

Asia-PacificCSL BehringHizentraImmunologicalsPharmaceuticalRare diseasesRegulation

Ablynx and Merck Serono expand collaboration on Nanobodies

Ablynx and Merck Serono expand collaboration on Nanobodies


Ablynx and Merck Serono have expanded their collaboration on the co-discovery and co-development of Nanobodies.

AblynxBiotechnologyEuropeImmunologicalsMerck SeronoNeurologicalOncologyResearch

Novartis links with Regenerex in cell therapy research collaboration


Swiss drug major Novartis (NOVN: VX) has entered into an exclusive global licensing and research collaboration…


Swedish researcher report on unexpected use of former cancer drug


Researchers at Sweden's Lund University have unexpectedly discovered that an old cancer drug - zebularine…


Actavis challenges Rayos patent


US generic drugmaker Actavis (NYSE: ACT) has confirmed filing an Abbreviated New Drug Application with…

ActavisGenericsHorizon PharmaImmunologicalsInflammatory diseasesPatentsRayos

US firms establish strategic partnership around biosimilars


Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

Novartis enters into a collaboration for Il-17 inhibitor


US biotech firm Ensemble Therapeutics, a company developing Ensemblins, a novel class of small molecule…

BiotechnologyEnsemble TherapeuticsImmunologicalsInflammatory diseasesLicensingNovartisPharmaceutical

Teijin and Amgen join forces on autoimmune disease research


Japan's Teijin Pharma, the core company of the Teijin Group's (TSE: 3401) health care business, has entered…

AmgenBiotechnologyImmunologicalsInflammatory diseasesLicensingPharmaceuticalResearchTeijin

Pfizer legacy company agrees near half billion dollar settlement with DoJ


Wyeth Pharmaceuticals, a US pharma rival acquired by US behemoth Pfizer (NYSE:PFE) in 2009, has agreed…

FinancialImmunologicalsLegalMarkets & MarketingNorth AmericaPfizerPharmaceuticalRapamuneWyeth

FDA backs Astellas' Astragraf XL for kidney transplant rejection prophylaxis


The US Food and Drug Administration has approved Japanese drug major Astellas Pharma's (TYO: 4503) Astragraf…

Astellas PharmaAstragraf XLImmunologicalsNorth AmericaPharmaceuticalRegulationtacrolimus

Merck Serono sets up new platform for cancer therapies innovation


Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Positive Ph III findings on ALK's new house dust mite allergy immunotherapy; EU filing expected in 2014


Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced positive outcome of the first of…

ALK AbelloImmunologicalsPharmaceuticalRegulationResearchRespiratory and Pulmonary

Additional indications in Japan for Roche's Avastin and Astellas' Prograf


Swiss drug major Roche (ROG: SIX) says that the Japanese Ministry of Health, Labor and Welfare (MHLW)…

Asia-PacificAstellas PharmaAvastinBiotechnologyImmunologicalsOncologyPharmaceuticalPrografRegulationRoche

Immune Design joins forces with academia for novel immunotherapy research


Privately-held US biotech firm Immune Design, the Cancer Research Institute (CRI) and the Ludwig Institute…

BiotechnologyImmune DesignImmunologicalsResearch

Baxter and Halozyme's HyQvia approved in European Union


USA-based Baxter International (NYSE: BAX) and Halozyme Therapeutics (Nasdaq: HALO) say that the European…

BaxterBiotechnologyEuropeHalozyme TherapeuticsHyQviaImmunologicalsPharmaceuticalRegulation

US FDA accepts Merck & Co's BLA ragweed pollen allergy immunotherapy


US pharma giant Merck & Co (NYSE: MRK) revealed yesterday (May 8) that the Biologics License Application…

Alk-AbelloBiotechnologyImmunologicalsMerck & CoNorth AmericaPharmaceuticalRegulation

Resverlogix to spin-out RVX Thera to unlock epigenetics platform value


Canadian drugmaker Resverlogix (TSX:RVX), which is exploring a sale, says that its board of directors…

ApolipoproteinBiotechnologyImmunologicalsMergers & AcquisitionsOncologyResverlogixRVX TherapeuticsRVX-208

40 to 64 of 129 results

Back to top